ELIQUENT Life Sciences
Andreas Tsitsos is the Chief Corporate Development Officer at ELIQUENT Life Sciences. Prior to this role, Andreas was the VP of Finance & Operations at Exeevo and held various positions at Syneos Health (previously INC Research/inVentiv Health), including Director of Corporate Development and Associate Director of Corporate Strategy & Development. Andreas has extensive experience in strategic transactions such as mergers and acquisitions, divestitures, and joint ventures. With a background in finance and corporate development, Andreas has successfully led global cross-functional teams through complex due diligence processes and negotiated transaction documents. Additionally, Andreas has a strong track record of creating value through strategic partnerships and business initiatives.
This person is not in any offices
ELIQUENT Life Sciences
We are expert consultants delivering the answers and solutions that life sciences innovators need to gain and maintain market authorization for their products. Our unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly to unlock excellence throughout the product lifecycle. We are the convergence of regulatory expertise and technical capabilities across the therapeutic landscape. From thought to finish, concept to commerce, and strategy to execution— ELIQUENT Life Sciences is the singular regulatory resource that clients around the world trust. ELIQUENT Life Sciences is comprised of five global consultancies working as a collective, coordinated regulatory team. The ELIQUENT team includes: VALIDANT: A full-service life science consulting firm providing strategy, execution, and ongoing support for a range of regulatory, compliance, and quality needs. GREENLEAF HEALTH: A leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. DATAREVIVE: A regulatory consultancy firm with expertise to deliver CMC, preclinical, clinical, and GxP expertise to innovators seeking product approvals in major global markets. ORIEL STAT-A-MATRIX: A global leader in training and consulting for business process improvement, regulatory compliance, and quality management systems. IDEC: A regionally specialized regulatory guidance and end-to-end product support for pharmaceutical innovators seeking approval in the Japanese market. Together, ELIQUENT redefines regulatory consulting with a full-service approach and comprehensive solutions that bridge the spectrum of regulatory challenges. Learn more at ELIQUENT.com